Santen Pharmaceutical Co Stock Today
| SNPHY Stock | USD 9.41 0.18 1.95% |
Performance0 of 100
| Odds Of DistressLess than 42
|
Santen Pharmaceutical is trading at 9.41 as of the 20th of April 2024; that is 1.95 percent up since the beginning of the trading day. The stock's open price was 9.23. Santen Pharmaceutical has about a 42 percent probability of financial distress in the next few years of operation and has generated negative returns over the last 90 days. Equity ratings for Santen Pharmaceutical Co are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 21st of March 2024 and ending today, the 20th of April 2024. Click here to learn more.
Santen Pharmaceutical Co., Ltd. researches and develops, manufactures, and markets pharmaceuticals and medical devices in Japan and internationally. Santen Pharmaceutical Co., Ltd. was founded in 1890 and is headquartered in Osaka, Japan. Santen Pharmaceutical operates under Drug ManufacturersGeneral classification in the United States and is traded on OTC Exchange. The company has 388.22 M outstanding shares. More on Santen Pharmaceutical Co
Moving together with Santen Pink Sheet
| 0.63 | JNJ | Johnson Johnson Financial Report 18th of July 2024 | PairCorr |
Moving against Santen Pink Sheet
| 0.73 | HNHPF | Hon Hai Precision | PairCorr |
| 0.64 | GE | GE Aerospace Earnings Call This Week | PairCorr |
| 0.61 | AZNCF | AstraZeneca PLC Earnings Call This Week | PairCorr |
| 0.61 | AZN | AstraZeneca PLC ADR Earnings Call This Week | PairCorr |
| 0.61 | TRGP | Targa Resources Financial Report 2nd of May 2024 | PairCorr |
| 0.51 | AMZN | Amazon Inc Earnings Call This Week | PairCorr |
| 0.42 | WMT | Walmart Financial Report 16th of May 2024 | PairCorr |
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Santen Pink Sheet Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Santen Pharmaceutical's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Santen Pharmaceutical or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO | Akira Kurokawa |
| Business Concentration | Drug Manufacturers—General, Healthcare (View all Sectors) |
Santen Pharmaceutical Co [SNPHY] is a Pink Sheet which is traded between brokers as part of OTC trading. The company currently falls under 'Mid-Cap' category with a current market capitalization of 2.94 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Santen Pharmaceutical's market, we take the total number of its shares issued and multiply it by Santen Pharmaceutical's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Santen Pharmaceutical classifies itself under Healthcare sector and is part of Drug Manufacturers—General industry. The entity has 388.22 M outstanding shares.
Santen Pharmaceutical Co has accumulated about 69.53 B in cash with 46.04 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 176.84, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Santen Pharmaceutical Probability Of Bankruptcy
Ownership AllocationSanten Pharmaceutical maintains a total of 388.22 Million outstanding shares. About 100.0 % of Santen Pharmaceutical outstanding shares are held by general public with 0.02 % by institutional holders. Note that regardless of who owns the company, if the true value of the entity is less than the market is willing to pay for it, you may not be able to generate positive returns over time.
Check Santen Ownership Details
Santen Stock Price Odds Analysis
Based on a normal probability distribution, the odds of Santen Pharmaceutical jumping above the current price in 90 days from now is about 88.03%. The Santen Pharmaceutical Co probability density function shows the probability of Santen Pharmaceutical pink sheet to fall within a particular range of prices over 90 days. Assuming the 90 days horizon Santen Pharmaceutical has a beta of 0.3456. This usually implies as returns on the market go up, Santen Pharmaceutical average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Santen Pharmaceutical Co will be expected to be much smaller as well. Additionally, santen Pharmaceutical Co has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
Based on a normal probability distribution, the odds of Santen Pharmaceutical to move above the current price in 90 days from now is about 88.03 (This Santen Pharmaceutical Co probability density function shows the probability of Santen Pink Sheet to fall within a particular range of prices over 90 days) .
Santen Pharmaceutical Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Santen Pharmaceutical market risk premium is the additional return an investor will receive from holding Santen Pharmaceutical long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Santen Pharmaceutical. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Santen Pharmaceutical's alpha and beta are two of the key measurements used to evaluate Santen Pharmaceutical's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.72 | |||
| Standard Deviation | 2.54 | |||
| Variance | 6.46 | |||
| Risk Adjusted Performance | (0.01) |
Santen Stock Against Markets
Picking the right benchmark for Santen Pharmaceutical pink sheet is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Santen Pharmaceutical pink sheet price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Santen Pharmaceutical is critical whether you are bullish or bearish towards Santen Pharmaceutical Co at a given time. Please also check how Santen Pharmaceutical's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Santen Pharmaceutical without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Stock Screener Now
Stock ScreenerFind equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |
| All Next | Launch Module |
Santen Pharmaceutical Corporate Directors
Santen Pharmaceutical corporate directors refer to members of a Santen Pharmaceutical board of directors. The board of directors generally takes responsibility for the Santen Pharmaceutical's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Santen Pharmaceutical's board members must vote for the resolution. The Santen Pharmaceutical board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Satoshi Suzuki | Executive Officer, Chief Director of Planning | Profile | |
| Kanoko Ohishi | Independent Director | Profile | |
| Kenji Morishima | Executive Officer, Chief Director of Human Resources & Organization Development and CSR | Profile | |
| Sadatoshi Furukado | Senior Managing Executive Officer, Director of Medical Business, Director | Profile |
How to buy Santen Pink Sheet?
Before investing in Santen Pharmaceutical, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Santen Pharmaceutical. To buy Santen Pharmaceutical stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Santen Pharmaceutical. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Santen Pharmaceutical stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Santen Pharmaceutical Co stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Santen Pharmaceutical Co stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Santen Pharmaceutical Co, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments.
Already Invested in Santen Pharmaceutical Co?
The danger of trading Santen Pharmaceutical Co is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Santen Pharmaceutical is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Santen Pharmaceutical. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Santen Pharmaceutical is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Santen Pharmaceutical Co. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate. Note that the Santen Pharmaceutical information on this page should be used as a complementary analysis to other Santen Pharmaceutical's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Complementary Tools for Santen Pink Sheet analysis
When running Santen Pharmaceutical's price analysis, check to measure Santen Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Santen Pharmaceutical is operating at the current time. Most of Santen Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Santen Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Santen Pharmaceutical's price. Additionally, you may evaluate how the addition of Santen Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |